Crinetics Pharmaceuticals Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Pharming Group.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Leiden, NL HQ Leiden, NL |
Employees | Employees 29723% increase | Employees 404 |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 590.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $376.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) |
Gross profit | Gross profit €53m (FY, 2025) | Gross profit $341m (FY, 2025) |
Net income | Net income (€196.4m) (FY, 2025) | Net income $2.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Pharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View company